BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30988397)

  • 21. TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.
    Jouan-Lanhouet S; Arshad MI; Piquet-Pellorce C; Martin-Chouly C; Le Moigne-Muller G; Van Herreweghe F; Takahashi N; Sergent O; Lagadic-Gossmann D; Vandenabeele P; Samson M; Dimanche-Boitrel MT
    Cell Death Differ; 2012 Dec; 19(12):2003-14. PubMed ID: 22814620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RIPK1 prevents TRADD-driven, but TNFR1 independent, apoptosis during development.
    Anderton H; Bandala-Sanchez E; Simpson DS; Rickard JA; Ng AP; Di Rago L; Hall C; Vince JE; Silke J; Liccardi G; Feltham R
    Cell Death Differ; 2019 May; 26(5):877-889. PubMed ID: 30185824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis.
    Geng J; Ito Y; Shi L; Amin P; Chu J; Ouchida AT; Mookhtiar AK; Zhao H; Xu D; Shan B; Najafov A; Gao G; Akira S; Yuan J
    Nat Commun; 2017 Aug; 8(1):359. PubMed ID: 28842570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JNK signaling prevents biliary cyst formation through a CASPASE-8-dependent function of RIPK1 during aging.
    Müller K; Honcharova-Biletska H; Koppe C; Egger M; Chan LK; Schneider AT; Küsgens L; Böhm F; Boege Y; Healy ME; Schmitt J; Comtesse S; Castoldi M; Preisinger C; Szydlowska M; Focaccia E; Gaisa NT; Loosen SH; Jörs S; Tacke F; Roderburg C; Keitel V; Bode JG; Boor P; Davis RJ; Longerich T; Geisler F; Heikenwalder M; Weber A; Vucur M; Luedde T
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33798093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3.
    Dillon CP; Weinlich R; Rodriguez DA; Cripps JG; Quarato G; Gurung P; Verbist KC; Brewer TL; Llambi F; Gong YN; Janke LJ; Kelliher MA; Kanneganti TD; Green DR
    Cell; 2014 May; 157(5):1189-202. PubMed ID: 24813850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRADD regulates perinatal development and adulthood survival in mice lacking RIPK1 and RIPK3.
    Dowling JP; Alsabbagh M; Del Casale C; Liu ZG; Zhang J
    Nat Commun; 2019 Feb; 10(1):705. PubMed ID: 30741936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis.
    Le Cann F; Delehouzé C; Leverrier-Penna S; Filliol A; Comte A; Delalande O; Desban N; Baratte B; Gallais I; Piquet-Pellorce C; Faurez F; Bonnet M; Mettey Y; Goekjian P; Samson M; Vandenabeele P; Bach S; Dimanche-Boitrel MT
    FEBS J; 2017 Sep; 284(18):3050-3068. PubMed ID: 28715128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis.
    Roderick JE; Hermance N; Zelic M; Simmons MJ; Polykratis A; Pasparakis M; Kelliher MA
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14436-41. PubMed ID: 25246544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NF-κB inhibition in keratinocytes causes RIPK1-mediated necroptosis and skin inflammation.
    Kumari S; Van TM; Preukschat D; Schuenke H; Basic M; Bleich A; Klein U; Pasparakis M
    Life Sci Alliance; 2021 Jun; 4(6):. PubMed ID: 33858959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caspase-8, receptor-interacting protein kinase 1 (RIPK1), and RIPK3 regulate retinoic acid-induced cell differentiation and necroptosis.
    Someda M; Kuroki S; Miyachi H; Tachibana M; Yonehara S
    Cell Death Differ; 2020 May; 27(5):1539-1553. PubMed ID: 31659279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.
    Lin J; Kumari S; Kim C; Van TM; Wachsmuth L; Polykratis A; Pasparakis M
    Nature; 2016 Dec; 540(7631):124-128. PubMed ID: 27819681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RIPK1 or RIPK3 deletion prevents progressive neuronal cell death and improves memory function after traumatic brain injury.
    Wehn AC; Khalin I; Duering M; Hellal F; Culmsee C; Vandenabeele P; Plesnila N; Terpolilli NA
    Acta Neuropathol Commun; 2021 Aug; 9(1):138. PubMed ID: 34404478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.
    Newton K; Dugger DL; Wickliffe KE; Kapoor N; de Almagro MC; Vucic D; Komuves L; Ferrando RE; French DM; Webster J; Roose-Girma M; Warming S; Dixit VM
    Science; 2014 Mar; 343(6177):1357-60. PubMed ID: 24557836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RIPK1 protects from TNF-α-mediated liver damage during hepatitis.
    Filliol A; Piquet-Pellorce C; Le Seyec J; Farooq M; Genet V; Lucas-Clerc C; Bertin J; Gough PJ; Dimanche-Boitrel MT; Vandenabeele P; Bertrand MJ; Samson M
    Cell Death Dis; 2016 Nov; 7(11):e2462. PubMed ID: 27831558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Casein kinase-1γ1 and 3 stimulate tumor necrosis factor-induced necroptosis through RIPK3.
    Lee SY; Kim H; Li CM; Kang J; Najafov A; Jung M; Kang S; Wang S; Yuan J; Jung YK
    Cell Death Dis; 2019 Dec; 10(12):923. PubMed ID: 31801942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
    Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
    Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis.
    Fauster A; Rebsamen M; Huber KV; Bigenzahn JW; Stukalov A; Lardeau CH; Scorzoni S; Bruckner M; Gridling M; Parapatics K; Colinge J; Bennett KL; Kubicek S; Krautwald S; Linkermann A; Superti-Furga G
    Cell Death Dis; 2015 May; 6(5):e1767. PubMed ID: 25996294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RIPK1 inhibits ZBP1-driven necroptosis during development.
    Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
    Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice.
    Camps G; Maestro S; Torella L; Herrero D; Usai C; Bilbao-Arribas M; Aldaz A; Olagüe C; Vales A; Suárez-Amarán L; Aldabe R; Gonzalez-Aseguinolaza G
    PLoS Pathog; 2024 May; 20(5):e1011749. PubMed ID: 38739648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Furosine, a Maillard Reaction Product, Triggers Necroptosis in Hepatocytes by Regulating the RIPK1/RIPK3/MLKL Pathway.
    Li H; Wang Y; Yang H; Zhang Y; Xing L; Wang J; Zheng N
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31091743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.